P508: THE PROGNOSTIC SIGNIFICANCE OF THE MEASURABLE RESIDUAL DISEASE STATUS WITHIN THE THREE AML ELN2022 RISK GROUPS

• Lara Bischof,
• Jule Ussmann,
• Dominic Brauer,
• Donata Backhaus,
• Georg-Nikolaus Franke,
• Vladan Vucinic,
• Uwe Platzbecker,
• Sebastian Schwind,
• Madlen Jentzsch

Affiliations

Lara Bischof

1 University of Leipzig Medical Center, Department of Hematology, Cell Therapy and Hemostaseology, Leipzig, Germany

Jule Ussmann

1 University of Leipzig Medical Center, Department of Hematology, Cell Therapy and Hemostaseology, Leipzig, Germany

Dominic Brauer

1 University of Leipzig Medical Center, Department of Hematology, Cell Therapy and Hemostaseology, Leipzig, Germany

Donata Backhaus

1 University of Leipzig Medical Center, Department of Hematology, Cell Therapy and Hemostaseology, Leipzig, Germany

Georg-Nikolaus Franke

1 University of Leipzig Medical Center, Department of Hematology, Cell Therapy and Hemostaseology, Leipzig, Germany

Vladan Vucinic

1 University of Leipzig Medical Center, Department of Hematology, Cell Therapy and Hemostaseology, Leipzig, Germany

Uwe Platzbecker

1 University of Leipzig Medical Center, Department of Hematology, Cell Therapy and Hemostaseology, Leipzig, Germany

Sebastian Schwind

1 University of Leipzig Medical Center, Department of Hematology, Cell Therapy and Hemostaseology, Leipzig, Germany

Madlen Jentzsch

1 University of Leipzig Medical Center, Department of Hematology, Cell Therapy and Hemostaseology, Leipzig, Germany